Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914475-25-000131
Filing Date
2025-05-22
Accepted
2025-05-22 17:28:01
Documents
1
Period of Report
2025-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1747949275.html 4  
1 FORM 4 wk-form4_1747949275.xml 4 9527
  Complete submission text file 0000914475-25-000131.txt   10984
Mailing Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130
Business Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Issuer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Sharp Shalini (Reporting) CIK: 0001377202 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22705 | Film No.: 25978358